Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T_3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy

Figure 3

In the group of patients with tumor sizes of less than 5 cm, the median survival times of the chemotherapy and without chemotherapy groups were 64.43 months and 62.38 months, respectively ().